The annual revenue for Hologic for 2023 in perinatal was $127MillionUSD (rounded) which had a growth of around 9% on the previous year. That segment includes FFN testing.
Worth noting, their entire perinatal and cytology segment was $485Million (rounded) for the same year. Cytology is also diagnostics for prenatal diagnosis and infectious disease detection.
I would hazard a guess that the market we could be looking at for LDX within Hologic is the $485Million.
Not out of the realm that revenues could be the size you reckon if we can access the higher segment.
LDX Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)